Private credit and structured financing becoming crucial for healthcare software platforms

A new report from Black Book Research indicates that private credit, bank facilities, and structured financing are becoming crucial components in healthcare software platforms, reshaping the competitive landscape in the industry.

The vendor-agnostic industry report, "Embedded Capital in Healthcare IT: The Product Stack and Capital Stack Are Converging," highlights that access to capital and the ability to integrate financing into provider, patient, and reimbursement workflows are emerging as critical differentiators. The study, directed at venture capital firms, private equity investors, investment banks, commercial lenders, private-credit funds, and healthcare technology corporate development executives, was compiled from insights from 82 healthcare investors, lenders, bankers, and strategic development professionals.

According to the findings, 80% of respondents expect capital to significantly impact healthcare IT products by 2029. Claims and payment data are seen as key determinants of the next competitive battle among healthcare platforms, with 77% of respondents identifying claims or reimbursement liquidity as an attractive embedded-capital application. This suggests that financing capacity is becoming as essential as software functionality in evaluating a platform's value.

Key findings from the report include: - 74% of respondents view capital access as a significant competitive capability. - 67% believe embedded financing can strengthen customer retention while creating concerns about vendor lock-in. - 66% identified bank or private-credit partnerships as the preferred capital structure. - 63% expect capital-enabled products to drive substantial transaction revenue.

Doug Brown, Founder of Black Book Research, emphasized that the next generation of healthcare IT winners will not be determined solely by software functionality. "Investors will need to identify platforms that can convert proprietary claims, payment, and workflow data into responsibly priced liquidity for providers and patients," he stated.

The report distinguishes traditional corporate borrowing from financing facilities directly tied to customer-facing services. It notes that embedded capital supports liquidity, payment guarantees, installment plans, equipment deployment, and risk-bearing arrangements. This distinction has significant implications for valuation and diligence, particularly in capital-intensive healthcare technology models.

The study introduces the Black Book Embedded Capital Intensity Index, a framework designed to help investors and transaction professionals determine the fundamental role of financing in a company's operations. The index evaluates ten dimensions, including credit capacity relative to equity, customer-facing capital deployment, and funding-partner durability.

Brown warned investors against valuing capital-enabled platforms solely based on conventional software-as-a-service metrics. "Two businesses with comparable recurring software revenue may have materially different economics depending on their reliance on warehouse facilities, reimbursement timing, loss reserves, covenants, or third-party funding," he said.

The report identifies several opportunities for investors, lenders, and strategic buyers, including claims advances, guaranteed provider payments, practice working capital, patient financing, hardware-as-a-service, and capital supporting provider participation in value-based care. These platforms are seen as having an underwriting advantage due to their real-time access to financial and transaction data.

Black Book Research expects the strongest near-term opportunities to arise from combining proprietary workflow and transaction data with regulated bank, private-credit, or insurance partners. Platforms retaining substantial balance-sheet risk may generate greater economics but will require more sophisticated funding, compliance, servicing, and risk-management capabilities.

For corporate development teams and financial sponsors, embedded capital may create several strategic opportunities, such as acquiring platforms controlling high-value claims and payment data, adding financing capabilities to existing EHR, RCM, and payment assets, and building partnerships between healthcare technology companies and lenders.

The report also highlights major diligence concerns, including facility concentration, covenant exposure, loss-adjusted economics, customer durability, state lending requirements, disclosure obligations, and the risk that apparent software growth is being subsidized by increasingly expensive capital.

The study is available on the Black Book Research website at <https://www.blackbookmarketresearch.com>.